71 related articles for article (PubMed ID: 23404487)
1. R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond.
Xu C; Garda AE; Kumar A
Curr Treat Options Oncol; 2023 Apr; 24(4):262-273. PubMed ID: 36847987
[TBL] [Abstract][Full Text] [Related]
2. The effect of physical therapy and mechanical stimulation on dysfunction of lower extremities after total pelvic exenteration in cervical carcinoma patient with rectovesicovaginal fistula induced by radiotherapy: a case report.
Lin W; Yao B; He J; Lin S; Wang Y; Chen F; Zhang W; Yang J; Ye Z; Qiu J; Wang Y
J Med Case Rep; 2024 Apr; 18(1):207. PubMed ID: 38610054
[TBL] [Abstract][Full Text] [Related]
3. Pelvic Exenteration - Past, Present and Future.
Duduş L; Minciună CE; Tudor Ș; Lăcătuş M; Vasilescu C
Chirurgia (Bucur); 2024 Apr; 119(2):201-210. PubMed ID: 38743833
[No Abstract] [Full Text] [Related]
4. Retrospective study of combined pelvic exenteration in the treatment of primary and recurrent pelvic malignant tumors.
Li C; Li Z; Zhang J; Zhang X; Siesto G; Li S; Ma P; Zhang J; Li Z; Zhao Y
J Gastrointest Oncol; 2024 Feb; 15(1):299-311. PubMed ID: 38482226
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience.
Tortorella L; Marco C; Loverro M; Carmine C; Persichetti E; Bizzarri N; Barbara C; Francesco S; Foschi N; Gallotta V; Avesani G; Chiantera V; Ercoli A; Fanfani F; Fagotti A; Mele MC; Restaino S; Gueli Alletti S; Scambia G; Vizzielli G
J Gynecol Oncol; 2024 Jan; 35(1):e4. PubMed ID: 37743057
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for locally advanced and recurrent prostate cancer.
Ephraums J; Brown KGM; Solomon MJ; Austin KKS; Lee PJ; Leslie S; Byrne C
Eur J Surg Oncol; 2024 May; 50(7):108384. PubMed ID: 38749360
[TBL] [Abstract][Full Text] [Related]
7. First-reported case of vaginal late recurrence of Wilms tumor treated with complete pelvic exenteration.
Pizzuti G; Quijano Y; Vicente E; Caruso R
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967928
[TBL] [Abstract][Full Text] [Related]
8. Treatment options in recurrent cervical cancer (Review).
Gadducci A; Tana R; Cosio S; Cionini L
Oncol Lett; 2010 Jan; 1(1):3-11. PubMed ID: 22966247
[TBL] [Abstract][Full Text] [Related]
9. Urological outcomes following pelvic exenteration for non-urological malignancies.
Lazarovich A; Drori T; Guttman Y; Rosenzweig B; Ben-Yaaqov A; Korach J; Nissan A; Dotan ZA
Heliyon; 2024 Apr; 10(8):e29640. PubMed ID: 38644885
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of autologous biological patch in preventing rectovaginal fistula after pelvic exenteration].
Wang Y; Yan QH; Wang GC; Wang T; Gao CQ; Li LJ; Ding LL; Zhang Z; Wang C; Zhang Y; Qi ZC
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):278-282. PubMed ID: 38532591
[No Abstract] [Full Text] [Related]
11. A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients.
Esmailzadeh A; Fakhari MS; Saedi N; Shokouhi N; Almasi-Hashiani A
BMC Cancer; 2024 May; 24(1):593. PubMed ID: 38750417
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
Yu JH; Tong CJ; Huang QD; Ye YL; Chen G; Li H; Wen YS; Yang F; Luo NB; Xu GY; Xiong Y
BMC Cancer; 2024 Jan; 24(1):88. PubMed ID: 38229045
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer - A Single Center Analysis.
Glane LT; Hegele A; Wagner U; Boekhoff J
Cancer Diagn Progn; 2022; 2(3):308-315. PubMed ID: 35530642
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies.
Murakami N; Okuma K; Okamoto H; Nakamura S; Kashihara T; Kaneda T; Takahashi K; Inaba K; Igaki H; Masui K; Yoshida K; Kato T; Itami J
J Contemp Brachytherapy; 2022 Feb; 14(1):52-59. PubMed ID: 35233235
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases.
Nguyen Xuan HT; Myriam D; Charlotte N; Richard D; Anne-Sophie B; Olivier TM; Arnaud M; Fabrice L
Gynecol Oncol Rep; 2018 Aug; 25():56-59. PubMed ID: 29998183
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
17. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
18. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
19. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
